Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 9:35 PM
Ignite Modification Date:
2025-12-24 @ 9:35 PM
NCT ID:
NCT00286832
Eligibility Criteria:
Inclusion Criteria:
* Age ≥ 18 years.
* Newly diagnosed consecutive patients with diffuse large B-cell lymphoma (DLBCL) according to the WHO classification.
* Ann Arbor stage IIB-IV.
* Written informed consent.
Exclusion Criteria:
* Previously treated with chemotherapy or irradiation.
* Previous malignant diagnosis except basal cell carcinoma and cervical carcinoma in situ.
* Pregnancy.
* Lactation.
* Diabetes mellitus.
* Extreme adipositas.
* Claustrophobia.
* Active inflammatory disease or infection.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT00286832
Study Brief:
Protocol Section:
NCT00286832